ADIPOQ and myocardial infarction: This study and several others have provided detailed insights into the protective effects of adiponectin and confirmed the association between low adiponectin concentrations in obesity and CVD, like coronary artery disease, ventricular dysfunction, myocardial infarction, atherosclerosis, hypertension, and others [64].